KPV Chemistry: The Lys-Pro-Val Tripeptide
A bench-level reference sheet on KPV, the three-residue C-terminal fragment of alpha-MSH: how a tripeptide this short is built, how its identity is confirmed, and what to know before keeping one as a reference standard.
Sequence and Structure
KPV is one of the smallest peptides kept as a reference standard. Its sequence is just three residues, Lysine-Proline-Valine, written Lys-Pro-Val, and the one-letter code K-P-V is where the name comes from. With only two peptide bonds in the whole molecule it is a true tripeptide, linear and unmodified, and that compact size shapes almost everything about how it is made, analyzed, and stored.
Reading the sequence left to right gives a chemist most of what matters at a glance. The N-terminal lysine carries a basic side chain that influences solubility and how the peptide behaves on a reversed-phase column, the central proline introduces a rigid ring that constrains the backbone, and the C-terminal valine closes the chain with a small hydrophobic residue. Because there are so few positions, there is little room for the deletion and truncation sequences that complicate longer peptides, which is part of why a short fragment like this is a clean subject to work with.
Origin as the Alpha-MSH C-Terminal Fragment
KPV does not stand alone in nature. It corresponds to the final three residues of alpha-melanocyte-stimulating hormone, the 13-residue melanocortin peptide usually abbreviated alpha-MSH. The C-terminus of that parent sequence ends in Lys-Pro-Val, so KPV is best described as the C-terminal tripeptide fragment of alpha-MSH rather than as an independent invention. That lineage is why it is grouped as a melanocortin-derived tripeptide.
For a research chemist the family connection is useful context. Isolating the C-terminal end of a larger peptide and studying it on its own is a common way to probe which part of a sequence carries a given property, and a defined fragment like KPV is far easier to synthesize and characterize than the full parent. If you have read our overview on how peptide fragments relate to their parent sequences, the same logic applies here: the short fragment is the tractable, well behaved end of a longer melanocortin chain.
Synthesis by Fmoc Solid-Phase Peptide Synthesis
KPV is assembled by Fmoc solid-phase peptide synthesis, the same general method used across the reference catalog but applied to about the simplest possible target. The growing chain stays anchored to an insoluble resin while residues are added one at a time, from the C-terminal valine inward, each cycle removing the base-labile Fmoc protecting group and coupling the next protected amino acid before the chain is finally cleaved from the resin.
At three residues the build is short enough that the on-resin aggregation and difficult couplings that trouble long sequences are largely absent, so KPV is one of the more straightforward peptides to make cleanly. The lysine side chain is carried through the synthesis under standard protection and unmasked at cleavage. For a fuller treatment of the underlying method, see our overview on Fmoc solid-phase synthesis; the principles there scale directly down to a tripeptide.
How Identity and Purity Are Confirmed
Identity and purity for KPV are established with the same two complementary tools used across the catalog. Reversed-phase HPLC separates the target tripeptide from any minor related species and reports purity as the proportion of total peak area attributable to the main peak, while mass spectrometry confirms identity by matching the measured mass to the value expected for the Lys-Pro-Val sequence. Read together, the two methods describe both how much of the sample is the intended peptide and whether that main peak is in fact the right molecule.
What makes a short peptide like KPV a tidy analytical subject is that there are so few ways for the synthesis to go wrong. A three-residue chain has limited scope for deletion sequences, so the chromatogram tends to be simple to read and the mass assignment unambiguous. The point of this section is the method rather than any single figure: these are the techniques used to characterize the chemistry, and the documentation for a given standard is the reference of record for that material.
Stability and Storage
As a lyophilized powder, KPV is comparatively stable when kept cold, dry, and out of light. Long-term storage of the dry solid is typically at freezer temperatures, with the container protected from moisture so the powder does not pick up water on opening. Allowing a sealed vial to reach room temperature before it is opened helps avoid condensation forming on the cold contents.
Once reconstituted, the working solution is far less forgiving. Peptides in solution are subject to hydrolysis, oxidation, and adsorption to surfaces, so reconstituted material is generally held cold and used within a short window, with freeze-thaw cycles minimized. The proline in the middle of the chain gives the backbone a degree of rigidity, but these remain general handling principles for research peptides rather than claims about any one preparation. The documentation for a given standard should be the reference of record for its own conditions.
What KPV Is Studied For (Chemistry Only)
In a research-chemistry context, KPV is of interest mainly as a small, well defined model system. As the C-terminal fragment of a melanocortin peptide it lets chemists ask which properties of the larger sequence survive when only the last three residues remain, and a tripeptide this short is a convenient reference point when validating synthesis and analytical methods on related fragments. Much of the laboratory literature that mentions KPV frames it in an anti-inflammatory research context, where it appears as a melanocortin-derived sequence studied in cell and tissue models.
That framing is deliberately limited to the bench. KPV supplied as a reference standard is for laboratory research only, and nothing here describes or implies any human or veterinary use or outcome. Its value to a research chemist is as a chemistry subject: a compact, tractable melanocortin fragment whose behavior under synthesis, analysis, and storage is easy to characterize and worth knowing in detail. For neighboring material, our related overviews on melanocortin peptides place KPV alongside its parent sequence.
This overview is provided for laboratory and research use only. It is educational chemistry reference material and is not for human or veterinary consumption. Buyers are responsible for compliance with all applicable laws and regulations.
What is KPV?
KPV is a tripeptide with the sequence Lysine-Proline-Valine (Lys-Pro-Val). It corresponds to the three C-terminal residues of alpha-melanocyte-stimulating hormone (alpha-MSH), which makes it a small, well defined melanocortin-derived fragment. As a reference standard it is supplied as a lyophilized powder for laboratory research use only.
How does KPV relate to alpha-MSH?
KPV is the C-terminal tripeptide fragment of alpha-MSH. Alpha-MSH is a 13-residue melanocortin peptide, and its final three residues are Lys-Pro-Val. Studying KPV lets chemists work with the smallest end of that sequence on its own, isolated from the rest of the parent peptide, which is why it is described as a melanocortin-derived tripeptide.
How is KPV synthesized?
KPV is assembled by Fmoc solid-phase peptide synthesis. Because the chain is only three residues long it is one of the most straightforward peptides to build, with each residue added in turn on a resin support before cleavage. Identity and purity are then confirmed by reversed-phase HPLC and mass spectrometry.
How should KPV be stored?
As a lyophilized powder, KPV is kept cold, dry, and out of light, with long-term storage of the dry solid typically at freezer temperatures. Reconstituted solution is far less stable and is generally held cold and used within a short window. KPV is a reference standard for research use only, not for human or veterinary use.